Sign inJoin waitlistJoin the waitlist

Wilson Gonsalves

Professor of Medicine · Mayo Clinic College of Medicine and Science

Credentials: · · · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Hematology and Medical Oncology
Mayo Clinic College of Medicine and Science
2011–2014
Postdoctoral Certificate Mayo Clinic Center for Translational Scientific Activities
CHI Health Creighton University Medical Center
2008–2011
Creighton University School of Medicine
2004–2008

Research

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
Blood · 2017 · 269 citations
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
Blood Cancer Journal · 2018 · 250 citations
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma
Leukemia · 2013 · 181 citations

Shaji Kumar
285 papers
Morie Gertz
265 papers
Prashant Kapoor
265 papers
Angela Dispenzieri
260 papers
Francis Buadi
256 papers
David Dingli
235 papers
ML
Martha Lacy
218 papers
Taxiarchis Kourelis
217 papers · 7 as a fellow
Nelson Leung
215 papers
Suzanne Hayman
205 papers
Rahma Warsame
197 papers
SR
Sundararajan Rajkumar
196 papers

Grants

Assessment of Metabolites Among Asymptomatic Precursor and Malignant Monoclonal Gammopathies
National Cancer Institute · R01
Contact PI · $1.5M · Mayo Clinic Rochester
2021–2026
Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma
National Cancer Institute · K23
Contact PI · $512.6K · Mayo Clinic Rochester
2017–2020

Clinical trials

A Study of Carbon 13-based Deep Labelling of Bone Marrow Cells
Principal investigator · Enrolling by invitation
Mayo Clinic
2025–2027
Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma
Principal investigator · Terminated · Phase 2
Mayo Clinic
2022–2024
CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2019–2027
Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
Principal investigator · Completed · Phase 1
Mayo Clinic
2019–2023